Enteral oxygen therapy

PreclinicalSmall molecule

TTashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan

Enteral oxygen therapy is one of 2 small molecule programs targeting Rehabilitation. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

RehabilitationActive, not recruiting

RehabilitationPreclinical

Active, not recruiting

Competition

Competitive Landscape

1 competitor in Rehabilitation

#DrugCompanyPhaseTrials

Prolotherapy

MMayo Clinic

Preclinical

1 2

Enteral oxygen therapy

TTashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2028

N/AActive, not recruiting

Rehabilitation

NCT04702542

Clinical

Trials by Indication[1]

Rehabilitation1 trial

To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.

Active, not recruiting·TTashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan·N/A·NCT04702542·320 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Enteral oxygen therapy. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Enteral oxygen therapy compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Enteral oxygen therapy. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: TTashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan

Enteral oxygen therapy

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2028

Trials by Indication[1]

Rehabilitation1 trial

References

Drug Info

Quick Facts

Related News